Elite Pharmaceuticals, Inc.(ELTP)
Pharmaceuticals
Generic Pharmaceuticals
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-10-03 | Plassche Douglas EVP Operations | Sale | -800,000 | -18.60%3,500,000 | $0.62 | $499,200 | View SEC filing | |
| 2025-08-26 | ELITE PHARMACEUTICALS INC /NV/ EVP Operations | Sale | -500,000 | -21.74%1,800,000 | $0.52 | $262,150 | View SEC filing | |
| 2025-07-25 | Kirkov Kirko Chief Commercial Officer | Purchase | +16,366 | +100.00%16,366 | $0.59 | $9,640 | View SEC filing | |
| 2025-07-10 | Plassche Douglas EVP Operations | Sale | -200,000 | -8.00%2,300,000 | $0.58 | $115,800 | View SEC filing | |
| 2024-10-28 | Plassche Douglas SVP of Operations | Sale | -1,133,932 | -100.00%0 | $0.50 | $562,305 | View SEC filing | |
| 2016-03-21 | TREPPEL JERRY Other | Sale | -570,520 | -6.95%7,640,561 | $0.34 | $196,055 | View SEC filing | |
| 2016-02-24 | TREPPEL JERRY Other | Sale | -200,456 | -2.38%8,211,081 | $0.32 | $63,231 | View SEC filing | |
| 2016-02-18 | TREPPEL JERRY Other | Sale | -909,878 | -8.54%8,411,537 | $0.33 | $301,266 | View SEC filing | |
| 2015-11-18 | TREPPEL JERRY Chairman of Board | Sale | -150,000 | -1.60%9,196,769 | $0.30 | $45,253 | View SEC filing | |
| 2015-05-13 | NARINE JEENARINE Director | Sale | -9,345 | -5.09%5,682,877 | $0.41 | $125,170 | View SEC filing | |
| 2015-04-28 | Plassche Douglas Executive VP of Operations | Sale | -85,530 | -53.92%73,094 | $0.24 | $20,168 | View SEC filing | |
| 2014-09-29 | Hakim Nasrat A CEO & President | Purchase | +700,000 | +35.00%2,700,000 | $0.31 | $216,341 | View SEC filing | |
| 2014-05-13 | NARINE JEENARINE Director, 10% Owner | Sale | -329,437 | -5.64%5,510,455 | $0.38 | $125,944 | View SEC filing | |
| 2014-04-04 | NARINE JEENARINE Director, 10% Owner | Sale | -147,664 | -2.47%5,839,892 | $0.41 | $60,542 | View SEC filing | |
| 2014-03-31 | NARINE JEENARINE Director, 10% Owner | Sale | -190,172 | -3.08%5,987,556 | $0.43 | $81,165 | View SEC filing | |
| 2014-03-17 | NARINE JEENARINE Director, 10% Owner | Sale | -239,367 | -1.58%14,887,229 | $0.60 | $144,003 | View SEC filing | |
| 2014-03-17 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | -239,367 | -1.17%20,300,770 | $0.60 | $144,003 | View SEC filing | |
| 2014-03-17 | EPIC PHARMA LLC 10% Owner | Sale | -239,367 | -0.35%67,669,232 | $0.60 | $144,003 | View SEC filing | |
| 2014-03-17 | EPIC INVESTMENTS, LLC 10% Owner | Sale | -239,367 | -0.35%67,669,232 | $0.60 | $144,003 | View SEC filing | |
| 2014-03-10 | NARINE JEENARINE Director, 10% Owner | Sale | -1,824,500 | -6.30%14,939,890 | $0.77 | $1,407,330 | View SEC filing | |
| 2014-03-10 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | -1,824,500 | -5.07%20,372,580 | $0.77 | $1,407,330 | View SEC filing | |
| 2014-03-10 | EPIC PHARMA LLC 10% Owner | Sale | -1,824,500 | -2.62%67,908,599 | $0.77 | $1,407,330 | View SEC filing | |
| 2014-03-10 | EPIC INVESTMENTS, LLC 10% Owner | Sale | -1,824,500 | -2.62%67,908,599 | $0.77 | $1,407,330 | View SEC filing | |
| 2014-01-17 | NARINE JEENARINE Director, 10% Owner | Sale | -805,583 | -4.99%15,341,280 | $0.18 | $147,422 | View SEC filing | |
| 2014-01-17 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | -805,583 | -3.71%20,919,930 | $0.18 | $147,422 | View SEC filing |
1-25 of 233